Biotech
Lila Sciences
Lila Sciences raises $200M Series A at $800M valuation
$200M
Total Raised
Series A
Latest Round
2023
Founded
80+
Employees
San Francisco, CA
1 min read
Quick Facts
Valuation
$800M
Latest Round Size
$200M
Latest Round Date
March 2025
Lila Sciences: Series A Funding Round
Lila Sciences has successfully raised $200M in Series A funding, reaching a valuation of $800M.
Company Overview
Develops AI-powered platform for accelerating therapeutic antibody discovery
Funding Details
The Series A round was led by Foresite Capital, with participation from Perceptive Advisors.
Company Information
- Headquarters: San Francisco, CA
- Founded: 2023
- Employees: 80+
- Category: Biotech
Investment
Lila Sciences plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- Foresite Capital: Verified investor in Series A
- Perceptive Advisors: Verified investor in Series A
Key Investors
Foresite Capital
Lead Investor
Verified investor in Series A
Perceptive Advisors
Investor
Verified investor in Series A
About the Author
Editorial Team
Curated funding news from verified sources
Related Company Reports
Biotech
Orna Therapeutics
Orna Therapeutics Raises $251M Series B
Biotechnology company developing circular RNA therapeutics for cancer, genetic diseases, and infectious diseases
Emma Rodriguez
Oct 23, 2025
0 min read•$251M Series B
Biotech
Forge Biologics
Forge Biologics Raises $120M Series C
Gene therapy CDMO providing manufacturing and development services for AAV-based genetic medicines
Sarah Kim
Oct 23, 2025
0 min read•$120M Series C
Biotech
Vir Biotechnology
Vir Biotechnology Raises $250M
Clinical-stage immunology company developing treatments for infectious diseases including COVID-19, hepatitis B, and influenza
Sarah Kim
Oct 23, 2025
0 min read•$250M